It is 30 years since human T-cell leukemia virus type 1 (HTLV-1) was identified as the first
human retrovirus. To assess the implications of the virus for human health it is very important …

The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human
retrovirus discovered in 1980. It is estimated that around 10–20 million people are infected …

Most previous studies aimed at estimating the number of human T‐cell leukemia virus type‐
1 (HTLV‐1) carriers in endemic areas have been based on seroprevalence rates in blood …

Background HTLV-1 and HTLV-2 are retroviruses linked etiologically to various human
diseases, and both of them can be transmitted by vertical route, sexual intercourse, blood …

The number of HTLV-1 infected persons in the world has recently been estimated to be at
least at 5 to 10 million or perhaps higher due to unavailable data (Gessain and Cassar Front …

The human T-lymphotropic virus type 1 (HTLV-1; Retroviridae, Deltaretrovirus, Simian T
lymphotropic virus) is a pathogenic retrovirus that causes adult T-cell leukemia, HTLV-1 …

unpublished), supporting the infectious nature of HTLV. Nevertheless, the mechanism of
transmission of HTLV remains unproven. Since the incidence of HTLV seropositive T-cell …

BACKGROUND: The seroprevalence of Human T-cell Leukemia Virus Type 1 (HTLV-1) is
female predominant despite the higher incidence of Adult T-cell Leukemia (ATL) in males. If …

Background Human T-cell leukemia virus type 1 (HTLV-1) is a causative agent of the life-
threatening diseases, adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy …